Topic Hub
10 clinically reviewed articles, written and peer-reviewed by the HealthRX Medical Team.
Explore
Showing 10 of 10 clinical reviews.
Depression and anxiety are 2-3x more common in adults with type 2 diabetes. Learn how the bidirectional relationship affects HbA1c, treatment options, and screening guidelines from the ADA and APA.
Read clinical reviewEvidence-based guide to caregiver support, family involvement strategies, and community resources for managing Type 2 Diabetes at home.
Read clinical reviewA clinical guide to the most common comorbidities linked to type 2 diabetes, including cardiovascular disease, CKD, MASLD, obesity, hypertension, depression, and sleep apnea, with evidence-based screening recommendations.
Read clinical reviewA step-by-step walkthrough of the Type 2 Diabetes diagnostic algorithm, covering ADA and AACE criteria, screening thresholds, confirmatory testing, and differential diagnosis.
Read clinical reviewHow genetic variants and family history shape type 2 diabetes risk, which genes matter most, and what clinicians recommend for screening and prevention when hereditary risk is high.
Read clinical reviewA side-by-side comparison of ADA, AACE, Endocrine Society, and USPSTF guidelines for Type 2 Diabetes diagnosis, A1c targets, first-line therapy, and cardiovascular risk management.
Read clinical reviewHow Type 2 Diabetes management differs across special populations including older adults, pregnant women, adolescents, and those with CKD. Guidelines from ADA, AACE, and Endocrine Society with trial evidence.
Read clinical reviewA complete, guideline-backed monitoring schedule for type 2 diabetes covering HbA1c, lipids, kidney function, eye exams, foot checks, and more.
Read clinical reviewEvidence-based nutrition plans, exercise protocols, and lifestyle changes for managing type 2 diabetes, including ADA and AACE guideline recommendations, macronutrient targets, and meal timing strategies.
Read clinical reviewEvidence-based Type 2 Diabetes treatment algorithm covering first-line through fourth-line therapy, based on ADA 2024 Standards of Care, AACE guidelines, and landmark RCTs including UKPDS, EMPA-REG, and SUSTAIN-6.
Read clinical review